Saturday, April 26, 2025
HomeTagsHealthcare

Healthcare

Scenic Biotech and the Barth Syndrome Foundation Announce Partnership to Explore Genetic Modifiers to a Find Tailored Treatment for the Complex Rare Disease

Scenic Biotech BV ('Scenic' or 'the Company'), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for...

Cellphire Therapeutics Treats First Patient in Phase 2/3 Cryopreserved Platelets Clinical Trial

Cellphire Therapeutics, Inc., a biotechnology company developing next-generation pooled allogeneic cellular therapeutics for application across multiple medical indications, announced that the 1st patient has...

Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, announced the...

New Study Shows Electronic Tuning Fork (ETF) Improves Diabetic Ulcer Prediction

O'Brien Medical is pleased to announce the publication of a key research study validating the performance of its premier product, the ETF, in the...

Mission Bio Launches First-in-Class Single-Cell Genomics Solid Tumor Solution on Tapestri Platform

Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, launched the Tapestri Solution for Solid Tumor Research. This new end-to-end single-cell...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics